RANOLAZINE
- Product NDC
- 51407-226
- 11-digit product format
- 514070226
- Labeler code
- 51407
- Product ID
- 51407-226_a3319661-3d61-c754-e053-2995a90abd1d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RANOLAZINE
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Golden State Medical Supply
- Application
- ANDA211829
- Marketing category
- ANDA
- Marketing start
- 2019-06-04
- Marketing end
- 0000-00-00
- Substance
- RANOLAZINE
- Active strength
- 1000 mg/1
- Pharmacologic classes
- Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51407-226-60 | 51407022660 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 PACKAGE (51407-226-60) | 2019-06-06 | 0000-00-00 | No | No | Current |